Stevioside safety and benefits
A natural extract
from the leaves of Stevia rebaudiana Bertoni, what is the right dosage and which
product is best?
February 1 2017 by Dr. Ray Sahelian, M.D.
Stevioside is a natural sweetener extract from the stevia leaf becoming more popular since the FDA allowed it to be called a sweetener in 2008. The metabolism of stevioside leads to the formation of steviol. Stevioside is quite safe. Fertility and teratogenicity studies have not shown any major concerns for safety. Stevioside is of benefit for diabetics, PKU patients, as well as for obese persons intending to consume fewer calories by avoiding sugar supplements in the diet. No allergic reactions to it seem to exist. Stevioside is present in the stevia plant at levels up to 13%.
Safety, risk, caution, allergy and danger
As of 2017 no major side effects, allergies, physical or mental harm has
been reported in medical journals from the use of stevioside. Two
decades of research proove this natural sweetener is safe based on evaluation of the
published research on animals and humans.
Consumers want to know
I keep reading conflicting reports in magazines regarding the safety of stevia.
In your opinion, is it safe?
Stevia has been available to the consumer in the USA
since the mid 1990s and many people have used it daily for more than a decade
with absolutely no safety concerns. Based on a thorough evaluation of published
animal and human studies, we are confident that stevioside is safe and
significantly safer than practically all of the artificial sweeteners currently
on the market. Stevia extracts have been given in massive doses to three
generations of rodents with no harmful effects noted and it has been used in
Japan for more than 3 decades with no adverse reactions reported.
Weight loss, Does it help with weight loss?
It's difficult to say. One would think that consuming a substance that is sweet
and replaces sugar in some instances would lead to fewer calories consumed, but
this has not been the case with artificial sweeteners and we do not know if it
applies to stevia, also.
Used worldwide
Stevioside has been used for a number of years as a sweetener in South America,
Asia, Japan and China. It started becoming popular in the United States in the
mid 1990s.
Artificial sweeteners
There are many artificial sweeteners on the market, including aspartame,
saccharin, acesulfame-K, neotame, sucralose, cyclamate, and alitame. Since
stevia derived stevioside became available to the public in the late 1990s, more
people are using this natural sweetener. Rebaudioside A and stevioside are
steviol glycosides extracted from the plant Stevia rebaudiana Bertoni and are
used in several countries as food and beverage sweeteners.
Frequently asked questions regarding the benefits, uses, and safety
How sweet is stevioside compared to sugar?
It is 200 to 300 times sweeter than sucrose.
Can stevioside be used in cooking and baking?
Yes, it is heat stable.
Would stevioside use influence pregnancy and childbirth?
There is no evidence in humans that it has a
negative effect on pregnancy or cause genetic defects or difficulties with
labor.
How many milligrams of stevioside is safe to ingest daily?
Human studies are not available to determine how many
milligrams or grams of stevioside can be consumed safely each day. However,
rather than worrying about the specific amounts, as long as you are reasonable
in your intake of stevia products there is little or nothing to worry about. It
takes a very, very high amount of stevioside to cause any toxicity. A dosage of
15 grams per kilogram is about 1000 grams per human each day. Most people will
ingest less than 1 gram a day of stevioside even if they ingest a lot of stevia
products. The study below suggest stevioside and steviol are very safe. If
aspirin, acetaminophen or another medication is given at these dosages fatality
would occur quite quickly.
Acute toxicity of stevioside, a natural sweetener, and its metabolite,
steviol, in several animal species.
Drug Chem Toxicol. 1997; Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
The acute toxicity of stevioside and steviol (a product of enzymatic hydrolysis) was investigated in three animal species including rat, mouse and
hamster. The animals were treated intragastrically with stevioside or steviol
and general signs and symptoms were observed. The numbers of dead animals were
recorded within a period of 14 days after administration for estimation of LD50.
Stevioside at a dose as high as 15 g/kg body weight was not lethal to either
mice, rats or hamsters. Hamsters were found to be more susceptible to steviol
than rats or mice. LD50 values of steviol in hamsters were 5.20 and 6.10 g/kg BW
for males and females, respectively. In rats and mice, LD50 values of steviol
were higher than 15 g/kg BW in both sexes. Histopathological examination in the
kidney of hamsters induced by steviol revealed severe degeneration of the
proximal tubular cells. These structural alterations were correlated with the
increases in serum blood urea nitrogen (BUN) and creatinine. Therefore, the
possible cause of death induced by steviol might be due to acute renal failure.
How many calories are in stevioside?
It has no calories.
Benefit
A number of studies have suggested that, beside sweetness, stevioside along with
related compounds, which include rebaudioside A (second most abundant component
of S. rebaudiana leaf), steviol and isosteviol (metabolic components of
stevioside) may also offer therapeutic benefits, as they have
anti-hyperglycemic, anti-hypertensive, anti-inflammatory, anti-tumor, diuretic,
and immune influencing properties. However, more human research in varying
dosages needs to be published before we have a better understanding.
Stevioside and related compounds: therapeutic benefits beyond sweetness.
Pharmacol Ther. 2009. Department of
Physiology, Faculty of Science, Mahidol University, Bangkok,
Thailand.
Stevioside, an abundant component of Stevia rebaudiana leaf, has become
well-known for its intense sweetness (250-300 times sweeter than sucrose) and is
used as a non-caloric sweetener in several countries. A number of studies have
suggested that, beside sweetness, stevioside along with related compounds, which
include rebaudioside A (second most abundant component of S. rebaudiana leaf),
steviol and isosteviol (metabolic components of stevioside) may also offer
therapeutic benefits, as they have anti-hyperglycemic, anti-hypertensive,
anti-inflammatory, anti-tumor, anti-diarrheal, diuretic, and immunomodulatory
actions. It is of interest to note that their effects on plasma glucose level
and blood pressure are only observed when these parameters are higher than
normal. As steviol can interact with drug transporters, its role as a drug
modulator is proposed. This review summarizes the current knowledge of the
pharmacological actions, therapeutic applications, pharmacokinetics and safety
of stevioside and related compounds.
Use by patients with kidney disease, influence on renal
function
Q.
There is an internet web site that those with kidney disease should not use stevioside products. They were basing their conclusion on a study in rodents
that found stevioside was harmful to the kidneys. I read a few reports on Stevia
that reference the same study referred to below as footnote. I copied excerpts
below form an article I recently read. All of the reports state that there is an
issue of nephrotoxicity and that people with damaged kidneys are advised to stay
away from stevia until more research is available. I love the soft drinks made
by Zevia, including its cola, root beer and other flavors. And other than the
nephrotoxicity, it seems perfectly safe. I am not a medical person, so I did not
understand the study when I read it. My guess is that the rats in the study were
given exceptionally large dosages of stevia, a lot more than my 500 mgs a day. I
have 1-kidney, which is not 100% (if provides about 50% of what 2-kidneys did
for me) but it is stable and improving over time So if I am concerned about
losing nephrons if I continue consuming 500 mgs of stevia on a regular if not
daily basis. Can you comment on this?
A. Whenever researchers do studies in rodents, they often
give massive doses of the drugs or nutrients they are evaluating. The results
they obtain in many cases may not be relevant to humans. In the case of stevioside, the
intake in most humans will be a tiny fraction of what is given to the animals. Over
several decades of stevia and stevioside use by humans in Japan and other
countries, we have not seen reports of this natural sweetener extract to cause
kidney damage. It is up to you and your physician to review the published
studies and decide whether this sweetener is appropriate for your condition. The
stevioside study mentioned below refers to rats given an injection of 1500 mg of
stevioside per kilogram of body weight.
Chaivat Toskulkao, Deechakawan, “The Low Calorie
Natural Sweetener Stevioside: Nephrotoxicity and its Relationship to Urinary
Enzyme Excretion in the Rat”. Phytotherpy Research. Keywords: stevioside • stevia • sweetener • nephrotoxicity • lipid peroxidation • urinary
enzymes • glucosuria
The relationships between urinary enzyme levels and changes in blood urea
nitrogen (BUN) and plasma creatinine levels, along with simultaneous
ultrastructural changes of the kidney, were studied in rats treated with
stevioside. BUN levels increased at 3 h onward after subcutaneous injection (s.c.)
with stevioside (1.5 g/kg BW). The maximum increases in BUN and creatinine were
approximately 180% and 132% at 9 h after stevioside injection, respectively. At
this time, stevioside also caused significant increases in glucosuria, alkaline
phosphatase (AP) and -glutamyl transpeptidase (-GTP) but no significant changes
in proteinuria, N-acetyl--D-glucuronidase (NAG) or glutathione-S-transferase (GSH-S-TF).
Histopathological examination of the kidney induced by stevioside revealed
degeneration of the proximal convoluted tubule cells but no relation to lipid
peroxide formation was detected. These results suggest that stevioside induced
nephrotoxicity at the proximal convoluted tubules rather than at the glomeruli
and other tubules presumably by a defect of cell volume regulation due to
depletion of intracellular ATP and disruption of microvilli, and nuclear
dysfunction.
Stevioside effect on renal function of normal and
hypertensive rats.
J Ethnopharmacol. 1992. Departamento de Biologia, Faculdade de
Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo,
Brazil.
Physiological and pharmacological experiments have suggested that stevioside
from the leaves of Stevia rebaudiana acts as a typical systemic vasodilator. The
effect of stevioside on renal function in both normal and with experimental
renal hypertension rats was evaluated. Stevioside provoked hypotension, diuresis
and natriuresis in both the normal and hypertensive rats. Normal rats presented
an increase in renal plasma flow and glomerular filtration rate constant
following stevioside administration. The last effect is in part due to
vasodilation of both the afferent and efferent arterioles. Moreover, stevioside
infusion in hypertensive rats caused an increase in renal plasma flow and
glomerular filtration rate. These data are consistent with impairment of a renal
autoregulation mechanism in this experimental hypertensive model.
Blood pressure
Does stevioside increase or decrease blood pressure?
Studies thus far do not show stevioside to have a significant
effect on blood pressure, particularly since the amounts used are so small.
Blood sugar, insulin response, diabetes
Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia
rebaudiana.
Planta Med. 2005.
We have studied the effects of stevioside on the glucose and insulin metabolism
in 2 models of diabetes in rats, STZ-induced diabetic rats and NIDDM diabetic
rats induced by feeding with fructose. Stevioside (0.5 mg/kg), lowered the blood
glucose levels in STZ-induced diabetic rats, peaking at 90 min. Administered twice daily also demonstrated dose-dependent effects in lowering
the glucose levels in both diabetic rat models. It reduced the rise in
glucose during glucose tolerance testing in normal rats. In conclusion,
stevioside was able to regulate blood glucose levels by enhancing not only
insulin secretion, but also insulin utilization in insulin-deficient rats.
Stevioside inhibits atherosclerosis by improving insulin
signaling and antioxidant defense in obese insulin-resistant mice.
Int J Obes. Atherosclerosis and Metabolism Unit, Department of Cardiovascular
Diseases and Leuven Food Science and Nutrition Research Centre, Leuven, Belgium.
Stevioside is a non-caloric natural sweetener that does not induce a glycemic
response, making it attractive as sweetener to diabetics and others on
carbohydrate-controlled diets. Obesity is frequently associated with insulin
resistance and increased inflammation and oxidative stress. Therefore, we
investigated its effects on insulin resistance, inflammation and oxidative
stress related to atherosclerosis in obese insulin-resistant mice.
Twelve-week-old mice were treated with stevioside or
placebo for 12 weeks.Results:Stevioside had no effect on weight and
triglycerides, but lowered glucose and insulin. Stevioside treatment improved
adipose tissue maturation, and increased glucose transport, insulin signaling
and antioxidant defense in white visceral adipose tissues. Together, these
increases were associated with a twofold increase of adiponectin. In addition,
stevioside reduced plaque volume in the aortic arch by decreasing the
macrophage, lipid and oxidized low-density lipoprotein (ox-LDL) content of the
plaque. The higher smooth muscle cell-to-macrophage ratio was indicative for a
more stable plaque phenotype. The decrease in ox-LDL in the plaque was likely
due to an increase in the antioxidant defense in the vascular wall, as evidenced
by increased Sod1, Sod2 and Sod3. Circulating adiponectin was associated with
improved insulin signaling and antioxidant defense in both the adipose tissue
and the aorta of stevioside-treated mice. Stevioside treatment was associated
with improved insulin signaling and antioxidant defense in both the adipose
tissue and the vascular wall, leading to inhibition of atherosclerotic plaque
development and inducing plaque stabilization.
Is it safe for a person with diabetes?
Stevioside is a safe alternative to artificial
sweeteners in those who have diabetes.
Cancer
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and
related compounds.
Bioorg Med Chem. 2009. Faculty of
Pharmaceutical Sciences, Chiba Institute of Science, Choshi, Chiba,
Japan.
In a search for potential cancer chemopreventive agents from natural resources,
stevioside, a sweetener, and six related compounds, including two aglycones
steviol and isosteviol, were screened in an in vitro assay for inhibitory
effects on Epstein-Barr virus early antigen activation. Stevioside, steviol and
isosteviol showed significant activity in this assay and also exhibited strong
inhibitory effects in a two-stage carcinogenesis test using mouse skin induced
by 7,12-dimethylbenz[a]anthracene (DMBA) and
12-O-tetradecanoylphorbol-13-acetate (TPA). The inhibitory effects of these
three compounds were greater than that of glycyrrhizin. Furthermore, these three
compounds significantly inhibited mouse skin carcinogenesis initiated by
peroxynitrite and promoted by TPA. Their activities were comparable to that of
curcumin. These results suggested that stevioside, steviol and isosteviol could
be valuable as chemopreventive agents for chemical carcinogenesis.
Metabolism and excretion of stevioside
Comparative toxicokinetics and metabolism of rebaudioside A, stevioside, and
steviol in rats.
Food Chem Toxicol. 2008.
The toxicokinetics and metabolism of rebaudioside A, stevioside, and steviol
were examined in rats for comparative purposes to determine whether
toxicological studies conducted previously with stevioside would be applicable
to the structurally-related glycoside, rebaudioside A. Single, oral doses of the
radiolabelled compounds were extensively and rapidly absorbed with plasma
concentration-time profiles following similar patterns for stevioside and
rebaudioside A. Elimination of radioactivity from plasma was essentially
complete within 72h. All plasma samples had similar metabolite profiles; the
predominant radioactive component in all samples was steviol, with lower amounts
of steviol glucuronide(s) and low levels of one or two other metabolites.
Rebaudioside A, stevioside, and steviol were metabolized and excreted rapidly,
with the majority of the radioactivity eliminated in the feces within 48h.
Urinary excretion accounted for less than 2% of the administered dose for all
compounds in both intact and bile duct-cannulated rats, and the majority of the
absorbed dose was excreted via the bile. After administration of the compounds
to intact and bile duct-cannulated rats, radioactivity in the feces was present
primarily as steviol. The predominant radioactive compound detected in the bile
of all cannulated rats was steviol glucuronide(s), indicating de-conjugation in
the lower intestine. Overall, the data on toxicokinetics and metabolism indicate
that rebaudioside A and stevioside are handled in an almost identical manner.
Pharmacokinetics of rebaudioside A and stevioside after single oral doses in
healthy men.
Food Chem Toxicol. 2008. Medical Consultant, Northborough, MA, United States.
This study assessed the comparative
pharmacokinetics of steviol following single oral doses
of rebaudioside A and stevioside in healthy adult male subjects. Steviol
glucuronide appeared in the plasma of all subjects after administration of
rebaudioside A or stevioside. Steviol glucuronide was eliminated from the plasma,
with similar t1/2 values of approximately 14h for both compounds. Administration
of rebaudioside A resulted in a significantly (approximately 22%) lower steviol
glucuronide geometric mean Cmax value than administration of stevioside. Steviol
glucuronide was excreted primarily in the urine of the subjects during the 72h
collection period, accounting for 59% and 62% of the rebaudioside A and
stevioside doses, respectively. No steviol glucuronide was detected in feces.
Pharmacokinetic analysis indicated that rebaudioside A and stevioside underwent
similar metabolic and elimination pathways in humans with steviol glucuronide
excreted primarily in the urine and steviol in the feces. No safety concerns
were noted as determined by reporting of adverse events, laboratory assessments
of safety or vital signs.